These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9267820

  • 21. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
    Dellas A, Schultheiss E, Almendral AC, Gudat F, Oberholzer M, Feichter G, Moch H, Torhorst J.
    Int J Cancer; 1997 Aug 22; 74(4):421-5. PubMed ID: 9291432
    [Abstract] [Full Text] [Related]

  • 22. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.
    Zietz C, Rössle M, Haas C, Sendelhofert A, Hirschmann A, Stürzl M, Löhrs U.
    Am J Pathol; 1998 Nov 22; 153(5):1425-33. PubMed ID: 9811333
    [Abstract] [Full Text] [Related]

  • 23. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
    Agarwal S, Mathur M, Srivastava A, Ralhan R.
    Oral Oncol; 1999 Mar 22; 35(2):209-16. PubMed ID: 10435158
    [Abstract] [Full Text] [Related]

  • 24. [Pronostic value of the MDM-2 protein expression in the larynx cancer].
    García Lozano MC, Orradre Romero JL, Martínez Alvarez A, Sáez del Castillo AI, Piris Pinilla MA.
    An Otorrinolaringol Ibero Am; 2004 Mar 22; 31(6):571-82. PubMed ID: 15663089
    [Abstract] [Full Text] [Related]

  • 25. Apoptosis-associated proteins and the development of oral squamous cell carcinoma.
    Schoelch ML, Le QT, Silverman S, McMillan A, Dekker NP, Fu KK, Ziober BL, Regezi JA.
    Oral Oncol; 1999 Jan 22; 35(1):77-85. PubMed ID: 10211314
    [Abstract] [Full Text] [Related]

  • 26. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis.
    Blok P, Craanen ME, Dekker W, Offerhaus GJ, Tytgat GN.
    J Pathol; 1998 Sep 22; 186(1):36-40. PubMed ID: 9875138
    [Abstract] [Full Text] [Related]

  • 27. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Chen J, Lin J, Levine AJ.
    Mol Med; 1995 Jan 22; 1(2):142-52. PubMed ID: 8529093
    [Abstract] [Full Text] [Related]

  • 28. MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis.
    Li XJ, Murai M, Koyama T, Wang DY, Hashimoto K.
    Jpn J Cancer Res; 2000 May 22; 91(5):492-8. PubMed ID: 10835493
    [Abstract] [Full Text] [Related]

  • 29. Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations.
    Günther T, Schneider-Stock R, Häckel C, Kasper HU, Pross M, Hackelsberger A, Lippert H, Roessner A.
    Mod Pathol; 2000 Jun 22; 13(6):621-6. PubMed ID: 10874665
    [Abstract] [Full Text] [Related]

  • 30. mdm-2 oncogene expression in non-Hodgkin's lymphomas.
    Kawamata N, Miller C, Levy V, Shintaku IP, Koeffler HP, Said JW.
    Diagn Mol Pathol; 1996 Mar 22; 5(1):33-8. PubMed ID: 8919543
    [Abstract] [Full Text] [Related]

  • 31. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas.
    Waber PG, Chen J, Nisen PD.
    Cancer Res; 1993 Dec 15; 53(24):6028-30. PubMed ID: 8261417
    [Abstract] [Full Text] [Related]

  • 32. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM, Fleuren GJ, Kenter GG, Van den Broek LJ, Uljee SM, Hermans J, Van de Vijver MJ.
    Clin Cancer Res; 1999 Mar 15; 5(3):577-86. PubMed ID: 10100709
    [Abstract] [Full Text] [Related]

  • 33. p53 protein expression in laryngeal squamous cell carcinomas bearing wild-type and mutated p53 gene.
    Pruneri G, Pignataro L, Fracchiolla NS, Ferrero S, Capaccio P, Carboni N, Ottaviani A, Maiolo AT, Neri A, Buffa R.
    Histopathology; 1996 Jun 15; 28(6):513-9. PubMed ID: 8803594
    [Abstract] [Full Text] [Related]

  • 34. Immunohistochemical and molecular analysis of bax, bcl-2 and p53 genes in laryngeal squamous cell carcinomas.
    Fracchiolla NS, Capaccio P, Carboni N, Pagliari AV, Neri A, Ronchett D, Pruner G, Silvotti MG, Pignataro L, Buffa R, Broich G.
    Anticancer Res; 1999 Jun 15; 19(2A):1043-51. PubMed ID: 10368653
    [Abstract] [Full Text] [Related]

  • 35. A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinoma.
    Gorgoulis VG, Zoumpourlis V, Rassidakis GZ, Karameris A, Rassidakis AN, Spandidos DA, Kittas C.
    J Pathol; 1996 Oct 15; 180(2):129-37. PubMed ID: 8976869
    [Abstract] [Full Text] [Related]

  • 36. Expression of p53 and mdm-2 proteins in Hodgkin's Disease. Absence of correlation with the presence of Epstein-Barr virus.
    Tzardi M, Kouvidou C, Panayiotides I, Koutsoubi K, Stefanaki K, Giannikaki E, Darivianaki K, Zois M, Eliopoulos G, Kakolyris S, Delides G, Rontogianni D, Kanavaros P.
    Anticancer Res; 1996 Oct 15; 16(5A):2813-9. PubMed ID: 8917390
    [Abstract] [Full Text] [Related]

  • 37. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK.
    Int J Oncol; 2003 Feb 15; 22(2):409-14. PubMed ID: 12527941
    [Abstract] [Full Text] [Related]

  • 38. Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas.
    Ittmann M, Wieczorek R, Heller P, Dave A, Provet J, Krolewski J.
    Am J Pathol; 1994 Aug 15; 145(2):287-93. PubMed ID: 8053489
    [Abstract] [Full Text] [Related]

  • 39. Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics.
    Momand J, Zambetti GP.
    Oncogene; 1996 Jun 06; 12(11):2279-89. PubMed ID: 8649767
    [Abstract] [Full Text] [Related]

  • 40. Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas.
    Seki A, Kodama J, Miyagi Y, Kamimura S, Yoshinouchi M, Kudo T.
    Int J Cancer; 1997 Sep 26; 73(1):33-7. PubMed ID: 9334806
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.